Christine D. Baker

Insider Reports History

Entity
Individual
Location
C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine D. Baker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Operating Officer Stock Option (Right to Buy) 276K Apr 14, 2023 Direct
TYME TECHNOLOGIES, INC. Director Director Stock Option - Option to buy 0 Sep 16, 2022 Direct

Insider Reports Filed by Christine D. Baker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOOK HOOKIPA Pharma Inc. Apr 14, 2023 1 $0 4 Apr 18, 2023 Chief Operating Officer
TYME TYME TECHNOLOGIES, INC. Sep 16, 2022 3 $0 4 Sep 16, 2022 Director
TYME TYME TECHNOLOGIES, INC. Aug 24, 2022 1 $0 4 Aug 29, 2022 Director
HOOK HOOKIPA Pharma Inc. Jun 30, 2022 1 $0 4 Jul 1, 2022 Chief Operating Officer
HOOK HOOKIPA Pharma Inc. Apr 19, 2022 1 $0 4 Apr 20, 2022 Chief Business Officer
TYME TYME TECHNOLOGIES, INC. Mar 23, 2022 2 $0 4 Mar 25, 2022 Director
TYME TYME TECHNOLOGIES, INC. Mar 23, 2022 0 $0 3 Mar 25, 2022 Director
HOOK HOOKIPA Pharma Inc. Feb 1, 2022 2 $109K 4 Feb 1, 2022 Chief Business Officer